41. Rey M, Valenzuela-Fernandez A, Urzainqui A, Yanez-Mo M, Perez- Martinez M, et al. (2007) Myosin IIA is involved in the endocytosis of CXCR4 induced by SDF-1alpha. J Cell Sci 120: 1126–1133. 42. DeVries ME, Kelvin AA, Xu L, Ran L, Robinson J, et al. (2006) Defining the origins and evolution of the chemokine/chemokine receptor system. J Immunol 176: 401–415. 43. Strader CD, Fong TM, Graziano MP, Tota MR (1995) The family of G- protein-coupled receptors. Faseb J 9: 745–754. 44. Kofuku Y, Yoshiura C, Ueda T, Terasawa H, Hirai T, et al. (2009) Structural basis of the interaction between chemokine stromal cell-derived factor-1/ CXCL12 and its G-protein-coupled receptor CXCR4. J Biol Chem. 45. Wu M, Chen Q, Li D, Li X, Li X, et al. (2008) LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. J Cell Biochem 103: 245–255. 46. Marlow R, Strickland P, Lee JS, Wu X, Pebenito M, et al. (2008) SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res 68: 7819–7827. 47. Barrow KM, Ward CM, Rutter J, Ali S, Stern PL (2005) Embryonic expression of murine 5T4 oncofoetal antigen is associated with morphogenetic events at implantation and in developing epithelia. Dev Dyn 233: 1535–1545. 48. Hay DL, Poyner DR, Sexton PM (2006) GPCR modulation by RAMPs. Pharmacol Ther 109: 173–197. 49. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, et al. (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95: 9448–9453. 50. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595–599. 51. Sierro F, Biben C, Martinez-Munoz L, Mellado M, Ransohoff RM, et al. (2007) Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A 104: 14759–14764. 52. Griffiths RW, Gilham DE, Dangoor A, Ramani V, Clarke NW, et al. (2005) Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy. Br J Cancer 93: 670–677. 53. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor 5T4 Regulates CXCR4 Chemotaxis growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335–348. 54. Thelen M, Thelen S (2008) CXCR7, CXCR4 and CXCL12: An eccentric trio? J Neuroimmunol 198: 9–13. 55. Xu J (2005) Preparation, culture, and immortalization of mouse embryonic fibroblasts. Curr Protoc Mol Biol Chapter 28: Unit 28 21. 56. Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326: 292–295. 57. Mulryan K, Ryan MG, Myers KA, Shaw D, Wang W, et al. (2002) Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors. Mol Cancer Ther 1: 1129–1137. 58. Woods AM, Wang WW, Shaw DM, Ward CM, Carroll MW, et al. (2002) Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer. Biochem J 366: 353–365. 59. Shaw DM, Woods AM, Myers KA, Westwater C, Rahi-Saund V, et al. (2002) Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen. Biochem J 363: 137–145. 60. Irizarry R, Hobbs B, Collin F, Beazer-Barclay Y, Antonellis K, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264. 61. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5: -. 62. Smyth GK (2004) Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Statistical Applications in Genetics and Molecular Biology 3. 63. Southgate TD, Kingston PA, Castro MG (2001) Gene transfer into neural cells in vitro using adenoviral vectors. Curr Protoc Neurosci Chapter 4: Unit 4 23. 64. Hildinger M, Eckert HG, Schilz AJ, John J, Ostertag W, et al. (1998) FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells. Gene Ther 5: 1575–1579. 65. Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV (2008) Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol 18: 260–267. 66. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML (1997) Construction of adenovirus vectors through Cre-lox recombination. J Virol 71: 1842–1849. PLoS ONE | www.plosone.org 20 April 2010 | Volume 5 | Issue 4 | e9982